These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals.
    Author: Ahmad A, Menezes J.
    Journal: AIDS; 1996 Feb; 10(2):143-9. PubMed ID: 8838701.
    Abstract:
    OBJECTIVE: To determine the role of natural cellular cytotoxicity of peripheral blood mononuclear cells (PBMC) in killing of HIV-1 envelope protein-expressing, natural killer (NK)-sensitive human target cells, and to investigate this effector function in HIV-infected individuals. DESIGN AND METHODS: An HIV-1 env gene-containing expression vector was transfected into NK-sensitive K562 cells, and cell clones expressing gp120/41 were selected and used as targets in natural cytotoxicity assays using PBMC from both HIV-seropositive and seronegative individuals. A 16h 51Cr-release assay was used to determine the susceptibility of the gp120/41-expressing K562 as well as control vector-transfected cells. To identify the cell types involved in the killing of the transfected cells, PBMC depleted for a specific cell type as well as enriched or purified cell types were used as effector cells. RESULTS: Endogenous expression of gp120/41 by target cells increased their susceptibility to lysis by PBMC of HIV-seronegative individuals. The two cell types responsible for this enhanced killing, NK cells and monocytes, were found severely compromised in HIV-seropositive individuals in their ability to kill both env gene-transfected and control cells; killing by monocytes occurred via CD4. CONCLUSIONS: The present results illustrate for the first time that the transfected gp120/41 serves as target for both NK and monocyte-mediated killing and that cytocidal activity of these two effector cell types is defective in HIV-infected subjects. Strengthening this innate cytotoxic activity in these individuals may represent a valuable approach in controlling HIV infection.
    [Abstract] [Full Text] [Related] [New Search]